Skip to the page

Data / Form D filings / PEEL Therapeutics, Inc

PEEL Therapeutics, Inc: Form D filings

PEEL Therapeutics, Inc, a biotechnology company in Salt Lake City, UT, filed 2 Form D notices with the SEC between 2017 and 2019. The latest, on February 5, 2019, reports $9.3 million sold of a $10 million offering to 70 investors.

Find out what PEEL Therapeutics, Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1387 S AMBASSADOR WAY, Salt Lake City, UT, 84108
Phone
(650) 464-0747
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2015
Revenue range
No Revenues
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1719212

The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 5, 2019Amendment$10,000,000$9,252,000$748,00070Oct 6, 2017sec.gov
Oct 19, 2017New notice$7,500,000$5,620,000$1,880,00042Oct 6, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Avraham SchroederDirector
Joshua SchiffmanExecutive Officer, Director
James LevisonExecutive Officer

Other biotechnology companies in Utah that filed recently

Every Form D from the week of Feb 4, 2019 · All recent filings in Utah · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PEEL Therapeutics, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.